A RandomisEd ControLled TrIal of ChEwing Gum to RelieVE Thirst in Chronic Heart Failure (RELIEVE-CHF)

Sabine M Allida1, Sajad Shehab2, Sally C Inglis3

  • 1Neurological and Mental Health Division, The George Institute for Global Health, Sydney, NSW, Australia; IMPACCT Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia.

Insights

Chewing gum significantly reduced thirst in chronic heart failure patients. This intervention offers short-term and long-term relief for thirst, a common symptom in heart failure management.

Area of Science:

  • Cardiology
  • Symptom Management

Background:

  • Thirst is a prevalent and distressing symptom for patients with chronic heart failure (CHF).
  • Current interventions for thirst relief in CHF patients are limited.
  • Chewing gum has shown promise in managing thirst in patients on fluid restriction, such as those undergoing hemodialysis.

Purpose of the Study:

  • To evaluate the efficacy of chewing gum in alleviating thirst in individuals with chronic heart failure.
  • To assess the short-term (4 days) and longer-term (28 days) effects of chewing gum on thirst levels.

Main Methods:

  • A randomized controlled trial involving 71 patients with CHF on oral loop diuretics.
  • Participants were assigned to either a chewing gum group (n=36) or a control group (n=35) for two weeks.
  • Thirst levels were assessed at multiple time points: Days 1-4, Day 7, Day 14, and Day 28.

Main Results:

  • The chewing gum group demonstrated statistically significant improvements in thirst levels compared to the control group.
  • These improvements were noted at Day 4 (p=0.04) and Day 14 (p=0.02).

Conclusions:

  • Chewing gum effectively provides both short-term and long-term relief from thirst in patients with chronic heart failure.
  • This study offers valuable insights for designing future clinical trials focused on thirst management strategies in CHF.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
140
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
122
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
214
Regulation of Water Intake01:25

Regulation of Water Intake

Osmolality refers to the number of solute particles per kilogram of solvent in a solution. Plasma osmolality specifically indicates the total number of solute particles per kilogram of water in blood plasma. This value reflects the body's hydration status and is tightly regulated through mechanisms controlling water intake and output. While water consumption is a conscious decision, the body has intrinsic regulatory systems to maintain fluid balance. Dehydration, a state of water deficit...
2.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
401
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
661